Metagenomics Market to Reach USD 8.39 Billion by 2034: A Decade of Innovation and Growth

The global metagenomics market is poised for robust growth over the next decade, projected to surge from USD 2.36 billion in 2024 to USD 8.39 billion by 2034. This substantial expansion reflects a compound annual growth rate (CAGR) of 13.55% between 2025 and 2034. The increasing incidence of infectious diseases, alongside significant technological advancements, are primary factors driving this market trajectory.

Table of Contents

Market Overview

Metagenomics is the study of genetic material recovered directly from environmental or clinical samples. It provides a comprehensive view of microbial communities without the need for individual organism isolation and cultivation. Its applications span a wide range of industries including healthcare, environmental monitoring, agriculture, and biotechnology.

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/download-databook/5771

In 2024, North America emerged as the leading regional market, commanding 41% of the global revenue share. This dominance is attributed to a mature healthcare infrastructure and rapid adoption of next-generation sequencing (NGS) technologies. Meanwhile, the Asia Pacific region is anticipated to witness the fastest growth through 2034, fueled by a rising disease burden and improving diagnostic capabilities.

Segmental Insights

Product Type

Kits & Reagents: Dominated the market in 2024 due to their essential role in various metagenomic workflows. Their wide-ranging utility across applications drove demand.
Sequencing & Data Analytics Services: Expected to grow significantly, driven by the expanding use of NGS in pathogen identification and microbiome analysis, alongside decreasing sequencing costs.

Technology

Shotgun Sequencing: Led the market in 2024 owing to its high accuracy in detecting antibiotic resistance and genetic disorders. It has become indispensable in clinical diagnostics and microbial profiling.
16S rRNA Sequencing: Predicted to grow rapidly, especially for large-scale studies due to its speed, cost-effectiveness, and simplified data interpretation.

Get All the Details in Our Solutions – Access Report Preview: https://www.towardshealthcare.com/download-sample/5771

Workflow

Sequencing: Held the largest share in 2024, being the backbone of any metagenomics project. It enables identification of diverse microbes in samples from hospitals, labs, and agricultural fields.
Data Analysis: Poised for strong growth as the volume of sequencing data increases, necessitating advanced tools and skilled personnel to extract meaningful insights.

Application

Environmental Applications: Led in 2024 due to rising use in studying microbial ecosystems, soil fertility, pollution, and crop productivity.
Clinical Diagnostics: Expected to see robust growth due to the method’s utility in detecting antimicrobial resistance and enabling personalized medicine development.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com

Regional Trends

North America

Continues to lead the global market, supported by major industry players, research initiatives, and advanced laboratory facilities.

Asia Pacific

Set to experience the fastest CAGR due to:

Rising infectious disease prevalence.
Growing antibiotic resistance.
Government support and increasing R&D activities in countries like China and India.

China is leveraging metagenomics for personalized diet and treatment planning, while India is integrating it into genomics and biotech sectors with government backing.

Key Market Drivers

Rising Infectious Diseases

Metagenomics allows for the rapid and culture-free detection of pathogens, including rare and resistant strains, making it an indispensable diagnostic tool.

Technological Advancements

Innovations in sequencing platforms and bioinformatics software are enhancing performance and accessibility. Cloud-based solutions are being developed to predict antimicrobial resistance and streamline analysis.

Market Challenges

Complex Data Interpretation

The massive datasets generated by metagenomics demand high-level computational tools and expertise. Inaccurate interpretation can lead to diagnostic errors, limiting wider adoption.

Market Opportunities

AI Integration

Artificial intelligence is set to revolutionize metagenomics by:

Enhancing data interpretation.
Predicting disease outbreaks.
Supporting image analysis and clinical workflows.
AI-driven tools will also simplify the path from diagnosis to treatment, including vaccine development.

Recent Industry Developments

May 2025: Roche partnered with Broad Clinical Labs to deploy its Sequencing By Expansion (SBX) NGS technology for biomedical innovation.
April 2025: Tempus AI and Illumina joined forces to advance clinical adoption of NGS through AI-driven molecular testing.
October 2024: Universal Sequencing Technology launched TELL-Meta, enhancing applications of TELL-Seq linked-read technology.
June 2025: MGI announced its collaboration with GenePoweRx to support precision medicine across Asia Pacific.
May 2025: A genomics research partnership was announced in Thailand between Chulalongkorn University and PacBio to enhance newborn genetic screening.
May 2025: Bihar Agricultural University (India) inaugurated a Bioinformatics Lab combining AI, machine learning, and metagenomics for crop development.
April 2025: Metabolon, Inc. introduced a novel microbiome research toolkit integrating metabolite panels and sequencing technologies.